---
title: "\"Performance\" IWS GROUP's annual net profit of 4.15 million fell by 69.6%, with a final dividend of 0.3375 cents"
description: "IWS GROUP announced its financial results for the fiscal year ending in March, with revenue of HKD 435 million, an increase of 8.1% year-on-year. It recorded a net profit of HKD 4.15 million, a declin"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/244578628.md"
published_at: "2025-06-15T11:36:47.000Z"
---

# "Performance" IWS GROUP's annual net profit of 4.15 million fell by 69.6%, with a final dividend of 0.3375 cents

> IWS GROUP announced its financial results for the fiscal year ending in March, with revenue of HKD 435 million, an increase of 8.1% year-on-year. It recorded a net profit of HKD 4.15 million, a decline of 69.6%, with earnings per share of HKD 0.052. A final dividend of HKD 0.03375 per share was declared

IWS GROUP (06663.HK) announced its financial results for the fiscal year ending in March, with revenue of HKD 435 million, an increase of 8.1% year-on-year. It recorded a net profit of HKD 4.15 million, a decline of 69.6%, with earnings per share of HKD 0.0052. The final dividend is set at HKD 0.003375

### Related Stocks

- [0GJYS.HK - 国际永胜](https://longbridge.com/en/quote/0GJYS.HK.md)
- [06663.HK - IWS GROUP](https://longbridge.com/en/quote/06663.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| A Look At CK Hutchison Holdings (SEHK:1) Valuation After Recent Share Price Momentum | CK Hutchison Holdings (SEHK:1) has gained investor attention due to a strong share price performance, with a 19.3% retur | [Link](https://longbridge.com/en/news/276191173.md) |
| Standard Chartered PLC (OTCMKTS:SCBFF) Sees Significant Growth in Short Interest | Standard Chartered PLC (OTCMKTS:SCBFF) experienced a significant increase in short interest, rising 21.1% to 210,583 sha | [Link](https://longbridge.com/en/news/276119010.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/en/news/276113491.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.